Media Release: AGCS to focus on U.S. Large Corporate and Specialty insurance with sale of U.S. MidCorp and Entertainment businesses to Arch Insurance North America
Allianz Global Corporate & Specialty SE (‘AGCS’) to sell its Fireman’s Fund insurance businesses in the United States to Arch Insurance North America for... Read more.
Update to 2023 K-1 Tax Packages for Genesis Energy, L.P.
HOUSTON–(BUSINESS WIRE)–Genesis Energy, L.P. (NYSE: GEL) today announced that a revised 2023 State Schedule, included as part of the 2023 K-1 tax packages,... Read more.
Dry Eye Syndrome Market Set for Rapid Growth as Aging Population Demand Soars – Global Long-term Forecast to 2028 and 2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Syndrome Global Market Report 2024” report has been added to ResearchAndMarkets.com’s offering.... Read more.
Popular, Inc. Declares Dividend on Preferred Stock and Announces Distribution on Trust Preferred Securities
SAN JUAN, Puerto Rico–(BUSINESS WIRE)–Popular, Inc. (NASDAQ: BPOP) announced today that it has declared the following monthly cash dividend on its outstanding... Read more.
Popular, Inc. Declares Dividend on Preferred Stock and Announces Distribution on Trust Preferred Securities
SAN JUAN, Puerto Rico–(BUSINESS WIRE)–Popular, Inc. (NASDAQ: BPOP) announced today that it has declared the following monthly cash dividend on its outstanding... Read more.
Popular, Inc. Declares Dividend on Preferred Stock and Announces Distribution on Trust Preferred Securities
SAN JUAN, Puerto Rico–(BUSINESS WIRE)–Popular, Inc. (NASDAQ: BPOP) announced today that it has declared the following monthly cash dividend on its outstanding... Read more.
Curtiss-Wright to Announce First Quarter 2024 Financial Results
DAVIDSON, N.C.–(BUSINESS WIRE)–Curtiss-Wright Corporation (NYSE: CW) expects to release its first quarter 2024 financial results after the close of trading... Read more.
Core Scientific Announces March 2024 Production and Operations Updates
Earned 906 self-mined bitcoin and our customers earned an estimated 309 bitcoin at our data centers in March for a first quarter total of 2,825 self-mined bitcoin... Read more.
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial, with a 51% reduction in risk of disease progression or death... Read more.
Interface, Inc. to Host First Quarter 2024 Results Conference Call on May 3, 2024
ATLANTA–(BUSINESS WIRE)–Interface, Inc. (Nasdaq: TILE) announced today that it intends to release its first quarter 2024 results on Friday, May 3, 2024,... Read more.